Paving the way to a better future for high-risk patients.
Event:
ESC Congress 2015
Congress Presentation
About the speaker
Professor Kausik K Ray
Imperial College London, London (United Kingdom of Great Britain & Northern Ireland)
77
presentations
11
followers
3 more presentations in this session
Welcome and introduction - PCSK9 inhibition: an important step forward in treating dyslipidemia in high-risk patients.
Speaker: Professor E. Stroes (Amsterdam, NL)
PCSK9 inhibition: the road to effective management of high-risk patients.
Speaker: Professor J. Chapman (Paris, FR)
Closing remarks - PCSK9 inhibition: an important step forward in treating dyslipidemia in high-risk patients.
Speaker: Professor E. Stroes (Amsterdam, NL)
Access the full session
PCSK9 inhibition: an important step forward in treating dyslipidemia in high-risk patients
Speakers:
Professor K. Ray, Professor E. Stroes, Professor J. Chapman, Professor E. Stroes
About the event
ESC 365 is supported by
